natgillin/translations-raw huggingface dataset:
Since the entry into force of Council Regulation (EC) No 1/2003 (3) , undertakings can no longer notify their agreements to the Commission in order to receive an individual exemption from Article 101 TFEU, but are themselves responsible for assessing the legality of their agreements and practices.
Od začetka veljavnosti Uredbe Sveta (ES) št. 1/2003 (3) podjetja ne morejo več priglasiti svojih sporazumov Komisiji, da bi jim bila odobrena posamična izjema od člena 101 PDEU, temveč so sama odgovorna za to, da ocenijo zakonitost svojih sporazumov in praks.
The COVID-19 outbreak is a severe public health emergency for citizens and societies.
Izbruh COVID-19 je povzročil resne izredne razmere v javnem zdravju za državljane in družbe.
Depending on the evolution of the crisis, the Commission might amend or supplement this Communication in order to cover other forms of cooperation.
Komisija lahko glede na razvoj krize to sporočilo spremeni ali dopolni, da bi se zajele druge oblike sodelovanja.
Cooperation in the health sector might even need to go further to overcome critical supply shortages.
Na področju sodelovanja v zdravstvenem sektorju bo morda treba narediti še več, da bi odpravili kritično pomanjkanje zalog.
(6) See also the Commission Guidelines on the optimal and rational supply of medicines to avoid shortages during the COVID-19 adopted on 8 April 2020.
(6) Glej tudi Smernice o optimalni in racionalni oskrbi z zdravili za preprečevanje pomanjkanja med izbruhom COVID-19, sprejete 8. aprila 2020.
The Commission will apply this Communication as of 8 April, having regard to the impact of the COVID-19 outbreak, which requires immediate action.
Komisija bo to sporočilo uporabljala od 8. aprila ob upoštevanju učinkov izbruha COVID-19, ki zahtevajo takojšnje ukrepanje.
It may even be appropriate to provide undertakings with ad hoc feedback or comfort on the legality of specific cooperation initiatives.
Morebiti je celo primerno, da se podjetjem zagotovijo ad hoc povratne informacije ali zagotovilno pismo glede zakonitosti specifičnih pobud za sodelovanje.
It is also a major and unprecedented shock to the global and Union economies.
Prav tako je šok za svetovno gospodarstvo in gospodarstvo Unije, kakršnega še ni bilo.
The COVID-19 outbreak, its impact on the economy, and possible antitrust implications
Izbruh COVID-19, njegov vpliv na gospodarstvo in morebitne posledice za protimonopolna vprašanja
a temporary process that the Commissions has exceptionally set up to provide, where appropriate, ad hoc written comfort to undertakings in relation to specific and well-defined cooperation projects in this context.
začasni postopek, ki ga je Komisija izjemoma vzpostavila, da bi podjetjem po potrebi zagotovila ad hoc zagotovilno pismo v zvezi s specifičnimi in dobro opredeljenimi projekti sodelovanja v tem okviru.
This includes notably medicines and medical equipment (2) that are used to test and treat COVID-19 patients or are necessary to mitigate and possibly overcome the outbreak.
To vključuje zlasti zdravila in medicinsko opremo (2) , ki se uporabljajo za testiranje in zdravljenje bolnikov s COVID-19 ali so potrebni za ublažitev in morebiti zaustavitev izbruha.
In light of the multi-faceted and asymmetric nature of the crisis, undertakings might face different challenges and thus might need to resort to different forms of cooperation.
Zaradi večplastne in asimetrične narave krize se lahko podjetja soočajo z različnimi izzivi in se morajo zato morda opreti na različne oblike sodelovanja.
Many EU Member States have indicated that they are already experiencing shortages of medicines used to treat patients with COVID-19 or are expecting such shortages to occur very soon.
Številne države članice EU so navedle, da se že soočajo s pomanjkanjem zdravil, ki se uporabljajo za zdravljenje bolnikov s COVID-19, ali pa pričakujejo, da bo do pomanjkanja prišlo zelo kmalu (6) .
The fact that a cooperation is encouraged and/or coordinated by a public authority (or carried out within a framework set up by the latter) is also a relevant factor to be taken into account to conclude that such cooperation would not be problematic under EU competition law or would not be an enforcement priority for the Commission.
Dejstvo, da javni organ sodelovanje spodbuja in/ali usklajuje (ali da se izvaja v okviru, ki ga je ta organ vzpostavil), je prav tako pomemben dejavnik, ki ga je treba upoštevati pri ugotavljanju, da tako sodelovanje ne bi bilo sporno z vidika konkurenčnega prava EU oziroma ga Komisija ne bi obravnavala kot prednostno nalogo za izvrševanje.
It will therefore continue to closely and actively monitor relevant market developments to detect instances of undertakings taking advantage of the current situation to breach EU antitrust law, either by engaging in anti-competitive agreements or abusing their dominant position.
Zato bo še naprej pozorno in dejavno spremljala pomemben razvoj dogodkov na trgu, da bi odkrila primere podjetij, ki trenutne razmere izkoriščajo za kršenje protimonopolnega prava EU, bodisi s sklepanjem protikonkurenčnih sporazumov bodisi z zlorabo prevladujočega položaja.
(1) Other factors exacerbating shortages include massive precautionary stockpiling throughout the distribution chain, the lockdown in factories due to quarantine or confinement measures, logistical issues caused by border closures, export bans, lockdowns in third countries supplying the EU.
(1) Drugi dejavniki, ki stopnjujejo pomanjkanje, so med drugim obsežno preventivno kopičenje zalog vzdolž celotne distribucijske verige, zaprtje tovarn zaradi karantene ali ukrepov osamitve, logistične težave zaradi zaprtja meja, prepovedi izvoza in zaustavitev proizvodnje v tretjih državah, ki dobavljajo izdelke v EU.
The exceptional circumstances of this time and its related challenges may trigger the need for undertakings to cooperate with each other in order to overcome or at least to mitigate the effects of the crisis to the ultimate benefit of citizens.
Trenutne izredne okoliščine in z njimi povezani izzivi lahko sprožijo potrebo podjetij po medsebojnem sodelovanju, da bi lahko premagala ali vsaj ublažila posledice krize v končno korist državljanov.
Such activities do not raise antitrust concerns, provided that they are subject to sufficient safeguards (such as no flow of individualised company information back to competitors), as indicated in the Commission's Guidelines on the applicability of Article 101 of TFEU to horizontal co-operation agreements (7) .
Take dejavnosti ne povzročajo protimonopolnih pomislekov pod pogojem, da zanje veljajo zadostni zaščitni ukrepi (na primer da se informacije o posameznem podjetju ne prenašajo konkurentom), kot je navedeno v Smernicah Komisije o uporabi člena 101 PDEU za sporazume o horizontalnem sodelovanju (7) .
The Commission may review the Communication on the basis of the evolution of the COVID-19 outbreak.
Komisija lahko sporočilo pregleda na podlagi razvoja izbruha COVID-19.
(8) In addition to the usual channels for contacting the European Commission or submitting an antitrust complaint (https://ec.europa.eu/competition/contacts/electronic_documents_en.html), individuals can help anonymously in the fight against cartels and other anti-competitive practices through the Commission's whistle blower tool (https://ec.europa.eu/competition/cartels/whistleblower/index.html).
(8) Poleg običajnih kanalov za stik z Evropsko komisijo ali za vložitev protimonopolne pritožbe (https://ec.europa.eu/competition/contacts/electronic_documents_en.html) lahko posamezniki v boju proti kartelom in drugim protikonkurenčnim praksam anonimno pomagajo prek orodja Komisije za žvižgače (https://ec.europa.eu/competition/cartels/whistleblower/index.html).
To increase production, undertakings might need to switch their production lines for some non-essential/non-shortage medicines (or other products) to medicines (or other products) necessary to address the outbreak.
Da bi podjetja povečala proizvodnjo, morajo morda svoje proizvodne linije za nekatera zdravila (ali druge izdelke), ki niso bistvena ali jih ne primanjkuje, preusmeriti v zdravila (ali druge izdelke), potrebne za obravnavo izbruha.
The Commission's leniency programme, which allows businesses to report their own involvement in a cartel in exchange for a reduction of the fine imposed on them, also remains fully applicable during these exceptional times (https://ec.europa.eu/competition/cartels/leniency/leniency.html).
Program prizanesljivosti Komisije, ki podjetjem omogoča, da prijavijo svoje sodelovanje v kartelu v zameno za znižanje globe, ki se jim naloži, se prav tako v celoti uporablja tudi v teh izjemnih razmerah (https://ec.europa.eu/competition/cartels/leniency/leniency.html).
Such cooperation could take place among undertakings active within the relevant sector to overcome this shortage, as well as between undertakings active in other sectors (e.g. certain undertakings converting part of their production lines to start producing scarce products).
Takšno sodelovanje bi lahko potekalo med podjetji, dejavnimi v zadevnem sektorju, da bi se odpravilo to pomanjkanje, pa tudi med podjetji, dejavnimi v drugih sektorjih (nekatera podjetja na primer del svojih proizvodnih linij preusmerjajo v proizvodnjo izdelkov, ki jih primanjkuje).
See also Commission Regulation (EU) No 1217/2010 of 14 December 2010 on the application of Article 101(3) of the Treaty on the Functioning of the European Union to certain categories of research and development agreements ( OJ L 335, 18.12.2010, p. 36 ) ("R&D Block Exemption Regulation"), Commission Regulation (EU) No 1218/2010 of 14 December 2010 on the application of Article 101(3) of the Treaty on the Functioning of the European Union to certain categories of specialisation agreements, ( OJ L 335, 18.12.2010, p. 43 ) ("Specialisation Block Exemption Regulation"), Commission Regulation (EU) No 316/2014 of 21 March 2014 on the application of Article 101(3) of the Treaty on the Functioning of the European Union to categories of technology transfer agreements ( OJ L 93, 28.3.2014, p. 17 ) ("Technology Transfer Block Exemption Regulation"), Commission Regulation (EU) No 330/2010 of 20 April 2010 on the application of Article 101(3) of the Treaty on the Functioning of the European Union to categories of vertical agreements and concerted practices ( OJ L 102, 23.4.2010, p. 1 ) ("Vertical Block Exemption Regulation").
Glej tudi Uredbo Komisije (EU) št. 1217/2010 z dne 14. decembra 2010 o uporabi člena 101(3) Pogodbe o delovanju Evropske unije za nekatere skupine sporazumov o raziskavah in razvoju ( UL L 335, 18.12.2010, str. 36 ) (uredba o skupinski izjemi za raziskave in razvoj), Uredbo Komisije (EU) št. 1218/2010 z dne 14. decembra 2010 o uporabi člena 101(3) Pogodbe o delovanju Evropske unije za nekatere skupine sporazumov o specializaciji in usklajena ravnanja ( UL L 335, 18.12.2010, str. 43 ) (uredba o skupinski izjemi za specializacijo), Uredbo Komisije (EU) št. 316/2014 z dne 21. marca 2014 o uporabi člena 101(3) Pogodbe o delovanju Evropske unije za skupine sporazumov o prenosu tehnologije ( UL L 93, 28.3.2014, str. 17 ) (uredba o skupinski izjemi za prenos tehnologije) in Uredbo Komisije (EU) št. 330/2010 z dne 20. aprila 2010 o uporabi člena 101(3) Pogodbe o delovanju Evropske unije za skupine vertikalnih sporazumov in usklajenih ravnanj ( UL L 102, 23.4.2010, str. 1 ) (uredba o skupinski izjemi za vertikalne sporazume).
(3) Council Regulation (EC) No 1/2003 of 16 December 2002 on the implementation of the rules on competition laid down in Articles 81 and 82 of the Treaty ( OJ L 1, 4.1.2003, p. 1 )
(3) Uredba Sveta (ES) št. 1/2003 z dne 16. decembra 2002 o izvajanju pravil konkurence iz členov 81 in 82 Pogodbe ( UL L 1, 4.1.2003, str. 1 ).
There is a general supply shock resulting from the disruption of supply chains, combined with an asymmetric demand shock caused by either an abrupt decline in consumer demand for certain products and services or a steep rise in demand for other products and services, notably those related to the health sector (including e.g. pharmaceutical companies, medical equipment producers, and their distributors).
Zaradi motenj v dobavnih verigah je prišlo do splošnega šoka pri dobavah, obenem pa se soočamo z asimetričnim šokom pri povpraševanju zaradi bodisi nenadnega upada povpraševanja potrošnikov po nekaterih izdelkih in storitvah ali izrazitega povečanja povpraševanja po drugih izdelkih in storitvah, zlasti tistih, povezanih z zdravstvenim sektorjem (vključno z na primer farmacevtskimi podjetji, proizvajalci medicinske opreme in njihovimi distributerji).
There is also uncertainty at this stage on both the duration and intensity of the shock, which mainly rest on factors that are not all in the control of undertakings, but rather on decisions by public authorities, driven inter alia by public health considerations.
Trenutno tudi ni gotovo, kako dolgo bo šok trajal in kako intenziven bo, kar je v glavnem odvisno od dejavnikov, na katere podjetja nimajo vedno vpliva, temveč o njih odločajo javni organi, ki se opirajo med drugim na premisleke v zvezi z javnim zdravjem.
(5) To this end, the Commission's Directorate General for Competition has already set up a dedicated webpage (https://ec.europa.eu/competition/antitrust/coronavirus.html) and a dedicated mailbox (COMP-COVID-ANTITRUST@ec.europa.eu) that can be used to seek informal guidance on specific initiatives.
V ta namen je Generalni direktorat Komisije za konkurenco že vzpostavil namensko spletno stran (https://ec.europa.eu/competition/antitrust/coronavirus.html) in namenski poštni predal (COMP-COVID-ANTITRUST@ec.europa.eu), ki se lahko uporabita za pridobitev neuradnih usmeritev za specifične pobude.
This shows that the response to emergency situations related to the COVID-19 outbreak might require different degrees of cooperation, with a varying scale of potential antitrust concerns.
To kaže, da lahko odziv na izredne razmere, povezane z izbruhom COVID-19, zahteva različne stopnje sodelovanja, pri katerih se lahko pojavijo različni protimonopolni pomisleki.
(6) Over the last weeks, the Commission has received several requests from undertakings and trade associations asking for guidance about their envisaged cooperation, notably in the health sector and in view of the risk of shortages of critical hospital medicines used to treat COVID-19 patients.
Komisija je v zadnjih tednih prejela več prošenj podjetij in panožnih združenj za usmeritve v zvezi z njihovim predvidenim sodelovanjem, zlasti v zdravstvenem sektorju, glede na tveganje pomanjkanja ključnih bolnišničnih zdravil, ki se uporabljajo za zdravljenje bolnikov s COVID-19.
(7) Communication from the Commission - Guidelines on the applicability of Article 101 of the Treaty on the Functioning of the European Union to horizontal co-operation agreements ( OJ C 11, 14.1.2011, p. 1 ).
(7) Sporočilo Komisije - Smernice o uporabi člena 101 Pogodbe o delovanju Evropske unije za sporazume o horizontalnem sodelovanju ( UL C 11, 14.1.2011, str. 1 ).
The Commission understands that cooperation between undertakings might help in more efficiently addressing the shortage of essential products and services during the COVID-19 outbreak and, in this context, undertakings might need specific guidance on their cooperation initiatives in order to facilitate their self-assessment.
Komisija razume, da bi lahko sodelovanje med podjetji pomagalo učinkoviteje obravnavati pomanjkanje bistvenih izdelkov in storitev med izbruhom COVID-19 in da bi v tem okviru podjetja morda potrebovala specifične usmeritve za svoje pobude za sodelovanje, da bi se olajšala njihova samoocena.
In the context of an imperative request from public authorities to undertakings to temporarily cooperate in response to urgency situations related to the current COVID-19 outbreak (e.g. to organise production and delivery to meet an urgent need to keep up the functioning of health care for COVID-19 patients), such cooperation is allowed.
V kontekstu nujnega poziva javnih organov, naj podjetja začasno sodelujejo v odziv na izredne razmere zaradi trenutnega izbruha COVID-19 (na primer pri organizaciji proizvodnje in dostave zaradi nujnosti ohranitve delovanja zdravstvenega varstva za bolnike s COVID-19), je takšno sodelovanje dovoljeno.
(5) See also the joint statement on the application of the antitrust rules during the COVID-19 crisis, issued jointly by the European Commission, the EFTA Surveillance Authority and the National Competition Authorities that together form the European Competition Network (https://ec.europa.eu/competition/ecn/202003_joint-statement_ecn_corona-crisis.pdf).
(5) Glej tudi skupno izjavo o uporabi protimonopolnih pravil med krizo zaradi izbruha COVID-19, ki so jo skupaj izdali Evropska komisija, Nadzorni organ Efte in nacionalni organi za konkurenco, ki skupaj sestavljajo Evropsko mrežo za konkurenco (https://ec.europa.eu/competition/ecn/202003_joint-statement_ecn_corona-crisis.pdf).
These requests provide a useful example of the types of cooperation that might be required to address emergency situations related to the current COVID-19 outbreak and their assessment under Article 101 TFEU, along the lines outlined below.
Te prošnje so koristen prikaz za vrste sodelovanja, ki bi lahko bile potrebne za obravnavanje izrednih razmer, povezanih s trenutnim izbruhom COVID-19, in njihovo oceno na podlagi člena 101 PDEU, v skladu s spodnjimi načeli.
Notably, the Commission will not tolerate conduct by undertakings that opportunistically seek to exploit the crisis as a cover for anti-competitive collusion or abuses of their dominant position (including dominant positions conferred by the particular circumstances of this crisis) by, for example, exploiting customers and consumers (e.g. by charging prices above normal competitive levels) or limiting production to the ultimate prejudice of consumers (e.g. by obstructing attempts to scale up production to face shortages of supply).
Komisija zlasti ne bo dopustila ravnanja podjetij, ki poskušajo preračunljivo izkoristiti krizo kot krinko za protikonkurenčno nedovoljeno dogovarjanje ali zlorabe svojega prevladujočega položaja (vključno s prevladujočimi položaji, do katerih je prišlo zaradi posebnih okoliščin te krize), na primer z izkoriščanjem strank in potrošnikov (npr. z zaračunavanjem cen nad običajno konkurenčno ravnjo) ali z omejevanjem proizvodnje v končno škodo potrošnikov (npr. z oviranjem poskusov povečanja proizvodnje za odpravo pomanjkanja zalog).
Share aggregate supply gap information, and request participating undertakings, on an individual basis and without sharing that information with competitors, to indicate whether they can fill the supply gap to meet demand (either through existing stocks or increase of production).
posreduje združene informacije o vrzelih v dobavi in sodelujoča podjetja (posamično in brez izmenjave teh informacij s konkurenti) pozove, naj navedejo, ali lahko zapolnijo vrzel v dobavi, da bi zadostila povpraševanju (bodisi z obstoječimi zalogami ali povečanjem proizvodnje).
Nevertheless, in the current exceptional circumstances, such measures would not be problematic under EU competition law or - in view of the emergency situation and temporary nature - they would not give rise to an enforcement priority for the Commission, to the extent that such measures would be: (i) designed and objectively necessary to actually increase output in the most efficient way to address or avoid a shortage of supply of essential products or services, such as those that are used to treat COVID-19 patients; (ii) temporary in nature (i.e. to be applied only as long there is a risk of shortage or in any event during the COVID-19 outbreak); and (iii) not exceeding what is strictly necessary to achieve the objective of addressing or avoiding the shortage of supply.
Kljub temu taki ukrepi v trenutnih izrednih razmerah ne bi bili sporni z vidika konkurenčnega prava EU oziroma jih - glede na izredne razmere in njihovo začasno naravo - Komisija ne bi obravnavala kot prednostne naloge za izvrševanje, če bi bili: (i) zasnovani tako in objektivno potrebni, da se dejansko na najučinkovitejši način poveča obseg proizvodnje za obravnavo ali preprečitev pomanjkanja bistvenih izdelkov ali storitev, kot so tisti, ki se uporabljajo za zdravljenje bolnikov s COVID-19; (ii) začasni (tj. da se uporabljajo le, dokler obstaja tveganje pomanjkanja oziroma v vsakem primeru med izbruhom COVID-19); in (iii) ne presegajo tistega, kar je nujno potrebno za dosego cilja, da se obravnava ali prepreči pomanjkanje zalog.
The Commission encourages pro-competitive cooperation aimed at addressing these challenges, notably in response to urgent situations related to the current COVID-19 outbreak, and it is committed to provide antitrust guidance and support to facilitate the proper and swift implementation of cooperation that is needed to overcome the crisis to the ultimate benefit of citizens.
Komisija podpira sodelovanje, ki spodbuja konkurenco in je namenjeno reševanju teh izzivov, zlasti v odziv na izredne razmere zaradi trenutnega izbruha COVID-19, in se zavezuje, da bo zagotovila protimonopolne usmeritve in podporo za olajšanje pravilnega in hitrega izvajanja sodelovanja, potrebnega za izhod iz krize v končno korist državljanov.
The present Communication covers possible forms of cooperation between undertakings in order to ensure the supply and adequate distribution of essential scarce products and services during the COVID-19 outbreak and thus address the shortages of such essential products and services resulting first and foremost from the rapid and exponential growth of demand (1) .
To sporočilo zajema možne oblike sodelovanja med podjetji, da se zagotovita dobava in ustrezna distribucija bistvenih izdelkov in storitev, ki jih primanjkuje, med izbruhom COVID-19, in tako obravnava pomanjkanje takšnih bistvenih izdelkov in storitev, ki je predvsem posledica hitre in eksponentne rasti povpraševanja (1) .
In addition, output could be increased further and more efficiently if, at a certain site, only one medicine was produced (as opposed to switching production between different products, which requires time-consuming cleaning of machinery, etc.), balancing economies of scale with the need to avoid excessive reliance on any particular production site.
Poleg tega bi se obseg proizvodnje lahko dodatno in bolj učinkovito povečal, če bi se v določenem obratu proizvajalo samo eno zdravilo (namesto izmenične proizvodnje različnih izdelkov, zaradi česar je potrebno zamudno čiščenje strojev itd.), s čimer bi ekonomijo obsega uskladili s tem, da se je treba izogniti prekomerni odvisnosti od določenega proizvodnega obrata.
With a view to increasing the degree of legal certainty as regards antitrust guidance within a timeframe that is compatible with the urgency of certain situations related to the current COVID-19 outbreak, the Commission, through its Directorate General for Competition, stands ready, exceptionally and at its own discretion, to provide such guidance by means of an ad hoc "comfort" letter.
Da bi se povečala stopnja pravne varnosti v zvezi s protimonopolnimi usmeritvami v časovnem okviru, ki je združljiv z nujnostjo nekaterih razmer zaradi trenutnega izbruha COVID-19, je Komisija pripravljena, da prek Generalnega direktorata za konkurenco izjemoma in po lastni presoji zagotovi take usmeritve z ad hoc zagotovilnim pismom.
Measures to adapt production, stock management and, potentially, distribution in the industry may require exchanges of commercially sensitive information and a certain coordination of which site produces which medicines, so that not all undertakings focus on one or a few medicines, while others remain in under-production.
Ukrepi za prilagajanje proizvodnje, upravljanja zalog in potencialno distribucije v industriji lahko zahtevajo izmenjavo poslovno občutljivih informacij in določeno usklajevanje glede tega, kje se proizvaja katero zdravilo, zato da se ne bi vsa podjetja osredotočila na eno ali nekaj zdravil, druga pa bi se proizvajala v premajhnih količinah.